Global Cosmetics Regulations 2025

Moderator

Francesca Santacatterina

Regulatory and Compliance Analyst, Enhesa Product Intelligence

• what are the new requirements for the management of cosmetic ingredients; and
• other important new cosmetic regulations.

April Guo

General Manager, Personal and Home Care Division, CIRS Group China

• Review of Regulation (EC) No. 1223/2009 (with final evaluation expected in 2026), and
• Legislative Simplification Initiative (targeted for publication in July 2025).

Sylwia Jaczewska

European Commission - DG Grow

Emma Trogen

Deputy Director General, Cosmetics Europe

• how the REACH Microplastic (SPM) restriction applies to cosmetics and how companies can prepare; and
• interaction with other EU regulations on sustainability and emerging actions on microplastics outside EU.

Paolo Bonamigo

Associate Director, Anthesis Group (Anthesis GmbH)

• explore whether Next Generation Risk Assessment (NGRA) principles are enabling regulatory use of animal-free approaches;
• review the global transition to animal-free regulatory science we’re witnessing in cosmetic product and ingredient safety assessment; and
• reflect whether we can accelerate & better support this transition through increased collaboration, integration, and use of artificial intelligence. 

Gavin Maxwell

Head of Regulatory Science – Strategy & Advocacy, Unilever

• provide updates on latest implementation of MoCRA regulations;
• discuss emerging state-level regulatory challenges in light of MoCRA’s preemption clause including ingredient bans, labeling requirements, and extended producer responsibility laws; and
• review the compliance challenges created by the patchwork of state-level regulations.

Bridget Corridon

Staff Counsel, Personal Care Products Council (PCPC)

• fragrance allergens – requirements and timelines;
• cosmetic ingredient hotlist updates (changes to the hotlist from February and August 2025 and the notice of consultation); and
• regulatory activity on PFAS relevant to cosmetics

Larissa Lefebvre

Unit Head, Cosmetic Unit, Risk Management Strategies Division, Consumer & Hazardous Products Safety Directorate Healthy Environments & Consumer Safety Branch (HECSB) Health Canada

• Toxic-Free Cosmetics Act Restrictions, including formaldehyde releasers; and
• safer cosmetic product identification and incentives.

Cheri Peele

Director of Government and Market Policy, Toxic-Free Future

• the requirements of the California Safe Cosmetics Act of 2005 (CSCA) and the Cosmetics Fragrance & Flavor Ingredient Right to Know Act of 2020 (CFFIRKA);
• how California’s laws differ from federal reporting requirements; and
• California’s new ingredient prohibitions.

Jude Balmin

Communications & Policy Lead, California Department of Public Health, California Safe Cosmetics Program (CSCP)

• Overview of FDA Tier 1 OMOR Pathway for new OTC sunscreen drug UV-filters: overview of dsm-firmenich’s pioneering submission for PARSOL® Shield (Bemotrizinol 6%)—the first-ever Tier 1 OMOR for a UV filter, backed by GRASE and MuST testing; and
• Public Health and Innovation Impact of this regulatory milestone:
• Access to more effective sun protection options, supporting broader efforts in skin cancer prevention.
• Enabling innovation in sunscreen design to meet diverse skin needs, consumer preferences, and performance/sustainability expectations.

Carl D'Ruiz

Head of Science, Advocacy, and Business Development, dsm-firmenich Beauty Care North America

• market access and registration simplification;
• trade bloc developments in Mercosur and the Andean community; and
• ingredient controls and substance bans.

Melissa Owen

Founder / Attorney, AMBIENTELEGAL USA